IRPC Public Company Limited (IRPC) is set to launch and offer bonds and digital bonds to general investors through ten financial institutions, with projected stable interest rates ranging from 3.70% ...

Bestselling author Veronica Roth, the creator of the Divergent franchise, reflects on the book series' most divisive ...

VIJAYAWADA: BJP MP D Purandeswari raised critical questions in the Lok Sabha on Thursday, pertaining to the progress of artificial water recharge structures, an ...

Having shown last week that its opioid alternative can reduce post-surgery pain, Tris Pharma is back with another slice of clinical data to show that the drug is less likely to be abused.

Tris Pharma has reported positive topline outcomes from its ALLEVIATE-1 Phase III trial of cebranopadol for treating moderate-to-severe acute pain in individuals post-abdominoplasty surgery.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We’ve got lots of news coming out of D.C. today ...